Software, AI, and the Digital Health Explosion
Authored by Becky Dahler
The MedTech landscape is currently undergoing its most significant transformation in decades. We are moving rapidly from a world of physical widgets and hardware-centric engineering to a digital-first ecosystem. While this shift promises a revolution in patient care, it also presents a daunting set of challenges that many organizations are finding difficult to navigate.
To win in this new era, companies must bridge the gap between “building a medical device” and “becoming a software powerhouse.”
The Challenge: A New Layer of Complexity
The fundamental problem is that the rules of the game have changed. Digital health isn’t just an “add-on” to existing hardware; it is a fundamental shift in how value is created and regulated.
- Software as a Medical Device (SaMD): We are seeing value migrate from the hardware itself to the software driving the solutions. This requires a total rethink of development lifecycles—moving from linear, rigid processes to the agile, iterative cycles required for software.
- The AI Transparency Gap: As AI and Machine Learning (AI/ML) take center stage in diagnostics and imaging, they bring “black box” problems. Validating these algorithms for performance, bias, and data quality is significantly more complex than testing a physical component.
- Moving Targets in Regulation: Traditional regulatory paths were built for products that stay the same once they hit the market. “Adaptive AI”—systems that learn and evolve post-deployment—requires a whole new approach to lifecycle oversight rather than a simple one-time approval.
- The Skills Gap: Most MedTech firms excel at mechanical and electrical engineering. However, they often lack deep, in-house expertise in high-stakes areas like cybersecurity, data science, and cloud-based product management.
The Path Forward: Navigating the Convergence
Success in the digital health explosion requires more than just good intentions; it requires a specialized, flexible strategy. To bridge the capability gap, leaders are increasingly leaning on integrated models and external expertise to move faster and more safely.
1. Mastering Software Excellence
Navigating this space requires end-to-end software development that doesn’t sacrifice safety for speed. This means building software architecture that is “compliant by design”—meeting IEC 62304 standards from day one while integrating cybersecurity at every level, rather than treating it as an afterthought.
2. Strategic AI/ML Integration
It’s not enough to have a great algorithm. You need a robust dataset strategy and clinical evaluation plan that aligns with evolving FDA and global guidance. This ensures your AI is not only effective but also transparent, validated, and ready for the rigors of regulatory submission.
3. Modernizing the Regulatory Pathway
The “old way” of filing for clearance doesn’t always fit digital products. Companies must develop sophisticated pathways that include SaMD classification, De Novo strategies, and global market entry plans that account for the unique nature of software.
4. Total Product Lifecycle Management
For adaptive algorithms, the work really begins after the launch. Establishing post-market monitoring and change management protocols is essential for tracking real-world performance and ensuring long-term compliance as the technology evolves.
5. Proving Value for Reimbursement
Finally, digital health must pay for itself. Solutions need to demonstrate clear clinical and economic value backed by Real-World Evidence (RWE). This is the only way to satisfy payers and ensure market access in an increasingly cost-conscious environment.
Conclusion
The convergence of software, AI, and healthcare is widening the gap between the “innovators” and the “legacy-bound.” The complexity is real, but it shouldn’t be a barrier to entry. Peritia (https://www.peritia.com) is uniquely positioned to help organizations bridge this capability gap. By offering integrated consulting models that span end-to-end software validation, AI clinical strategy, and dynamic regulatory pathway development, Peritia (https://www.peritia.com) provides the specialized expertise necessary to turn digital challenges into a permanent competitive advantage.
Furthermore, as the threat landscape evolves alongside these innovations, Blue Goat Cyber (https://bluegoatcyber.com/services/) provides the critical technical foundation to ensure patient safety remains the top priority. From Premarket Cybersecurity Services (https://bluegoatcyber.com/services/) like threat modeling and penetration testing to Postmarket Monitoring (https://bluegoatcyber.com/services/) and SBOM management, Blue Goat Cyber ensures that your digital health innovations are not just functional, but resilient against the cyber risks of 2026 and beyond.
Together, these strategic partnerships allow MedTech leaders to focus on what they do best: innovating to save lives.
About the Author
Becky Dahler is passionate about driving growth and operational excellence in MedTech, with a proven track record of leading multi-million-dollar initiatives that accelerate innovation and improve patient outcomes.
Becky has over 25 years of relevant industry experience which has included working with four MedTech start-ups — two successful and two that provided invaluable lessons—as well as work with Fortune 100 MedTech organizations. This breadth of perspective enables Becky to bring practical, end-to-end expertise to a MedTech product and help guide it efficiently and strategically to market.